“This is an important treatment option and today is a proud day for CSL Seqirus as an Australian company,” said CSL Seqirus Executive Medical Director Dr Jonathan Anderson. “We look forward to seeing decision-makers assess our application for funding so that more Australians can access NEFFY.” …
'It’s the first time in over 30 years that a new way of administering adrenaline has been approved in Australia'
February 16, 2026 Latest NewsBioPharma
Latest Video
Georgia Forrest
New Stories
-
Scientists identify highly specific targets that could transform multiple myeloma treatment
March 15, 2026 - - Australian Biotech -
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News -
The leadership challenge behind Australia’s medicine access gap
March 13, 2026 - - Latest News -
Australia’s top community pharmacists honoured at national awards
March 13, 2026 - - Latest News -
Australia has spent four decades having the wrong conversation about medicines access
March 13, 2026 - - Latest News -
‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event
March 13, 2026 - - Latest News